Peregrine Capital Management LLC Buys 6,913 Shares of HealthEquity, Inc. $HQY

Peregrine Capital Management LLC boosted its stake in HealthEquity, Inc. (NASDAQ:HQY) by 7.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 102,691 shares of the company’s stock after purchasing an additional 6,913 shares during the quarter. Peregrine Capital Management LLC owned about 0.12% of HealthEquity worth $9,732,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in HQY. Norges Bank acquired a new stake in shares of HealthEquity in the 2nd quarter valued at about $75,072,000. Westfield Capital Management Co. LP grew its stake in HealthEquity by 124.6% in the second quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock valued at $132,543,000 after acquiring an additional 701,819 shares during the period. AQR Capital Management LLC increased its holdings in shares of HealthEquity by 148.5% during the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock valued at $116,016,000 after acquiring an additional 661,795 shares in the last quarter. Man Group plc increased its holdings in shares of HealthEquity by 1,331.8% during the second quarter. Man Group plc now owns 254,652 shares of the company’s stock valued at $26,677,000 after acquiring an additional 236,867 shares in the last quarter. Finally, Viking Global Investors LP bought a new position in shares of HealthEquity in the 2nd quarter worth $23,021,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the stock. BTIG Research restated a “buy” rating and set a $130.00 price objective on shares of HealthEquity in a report on Thursday, December 4th. KeyCorp upped their price objective on HealthEquity from $120.00 to $125.00 and gave the company an “overweight” rating in a research note on Thursday. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $120.00 price target on shares of HealthEquity in a research report on Friday, December 5th. Barrington Research reaffirmed an “outperform” rating and issued a $125.00 price objective on shares of HealthEquity in a research report on Thursday, December 4th. Finally, BMO Capital Markets reissued a “market perform” rating on shares of HealthEquity in a research report on Thursday, December 4th. Two investment analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $119.60.

Insider Buying and Selling

In related news, EVP Delano Ladd sold 1,500 shares of the stock in a transaction on Friday, December 19th. The stock was sold at an average price of $94.72, for a total value of $142,080.00. Following the sale, the executive vice president owned 73,979 shares in the company, valued at approximately $7,007,290.88. This trade represents a 1.99% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Elimelech Rosner sold 10,959 shares of the business’s stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of $95.45, for a total value of $1,046,036.55. Following the transaction, the executive vice president owned 45,742 shares of the company’s stock, valued at approximately $4,366,073.90. The trade was a 19.33% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 15,459 shares of company stock worth $1,483,062 in the last ninety days. 1.50% of the stock is currently owned by insiders.

HealthEquity Stock Performance

NASDAQ HQY opened at $98.51 on Friday. The firm has a market cap of $8.42 billion, a P/E ratio of 45.19, a price-to-earnings-growth ratio of 1.41 and a beta of 0.20. The company has a quick ratio of 4.13, a current ratio of 4.13 and a debt-to-equity ratio of 0.46. The company’s 50 day moving average is $97.05 and its 200-day moving average is $95.31. HealthEquity, Inc. has a 12-month low of $74.07 and a 12-month high of $116.65.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The firm had revenue of $322.16 million for the quarter, compared to the consensus estimate of $320.92 million. During the same quarter in the prior year, the business posted $0.78 earnings per share. The business’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Sell-side analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.